Tributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3

Citation
Ko. Clarke et al., Tributyrin, an oral butyrate analogue, induces apoptosis through the activation of caspase-3, CANCER LETT, 171(1), 2001, pp. 57-65
Citations number
29
Categorie Soggetti
Onconogenesis & Cancer Research
Journal title
CANCER LETTERS
ISSN journal
03043835 → ACNP
Volume
171
Issue
1
Year of publication
2001
Pages
57 - 65
Database
ISI
SICI code
0304-3835(20010928)171:1<57:TAOBAI>2.0.ZU;2-T
Abstract
The purpose of this study was to investigate the anti-proliferative and pro -apoptotic effects of the butyrate analogues, tributyrin (TB) and phenylbut yrate (PB), in a colon cancer model. We demonstrate that HT-29 colon cancer cells exposed to PB and TB result in growth inhibition associated with an induction of apoptosis mediated through the activation of caspase-3 activit y. A block in the GUS cell cycle traverse associated with a decrease in CDK 2 (cyclin dependent kinase) protein levels and retinoblastoma protein hypop hosphorylation was also noted after PB and TB exposure. Importantly, TB pro ved to be the most potent agent in its ability to induce these phenotypic c hanges, and potentially may represent a novel therapy for patients with adv anced colorectal cancer. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.